Laboratory Medicine and Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Breast Neoplasms 62%
3. Mutation 59%
4. Genes 53%
5. Survival 39%
6. Biopsy 33%
7. Fluorescence In Situ Hybridization 32%
8. Kidney 31%
9. Proteins 30%
10. Ovarian Neoplasms 28%
11. Prostatic Neoplasms 28%
12. Therapeutics 26%
13. Renal Cell Carcinoma 24%
14. Single Nucleotide Polymorphism 24%
15. Carcinoma 24%
16. Adenocarcinoma 22%
17. Colorectal Neoplasms 22%
18. Pathology 21%
19. Phenotype 21%
20. DNA 21%
21. Proteomics 20%
22. Chromosomes 20%
23. Genome 19%
24. Cytogenetics 19%
25. Antibodies 19%
26. Recurrence 19%
27. Biomarkers 18%
28. Serum 18%
29. Lung 17%
30. Immunoglobulin G 17%
31. Breast 17%
32. Lymphoma 17%
33. Glioma 17%
34. Neoplasm Metastasis 17%
35. Liver 16%
36. Alleles 16%
37. Pathologists 16%
38. Acute Myeloid Leukemia 16%
39. Confidence Intervals 15%
40. Mass Spectrometry 15%
41. Polymerase Chain Reaction 15%
42. Autoantibodies 15%
43. T-Lymphocytes 14%
44. Infections 14%
45. Bone Marrow 13%
46. Amyloidosis 13%
47. Cell Line 13%
48. Immunohistochemistry 13%
49. Genome-Wide Association Study 13%
50. B-Cell Chronic Lymphocytic Leukemia 13%
51. Hereditary Nonpolyposis Colorectal Neoplasms 13%
52. Microsatellite Instability 13%
53. Precursor Cell Lymphoblastic Leukemia-Lymphoma 13%
54. Fibrosis 13%
55. Endometrial Neoplasms 13%
56. Population 13%
57. Staining and Labeling 13%
58. Ovarian Epithelial Carcinoma 12%
59. Pancreatic Neoplasms 12%
60. Drug Therapy 12%
61. Growth 12%
62. B-Lymphocytes 12%
63. Gene Expression 11%
64. Transplants 11%
65. Methylation 11%
66. Glioblastoma 11%
67. High-Throughput Nucleotide Sequencing 11%
68. Odds Ratio 11%
69. Lymphoma, Large B-Cell, Diffuse 11%
70. Multiple Myeloma 11%
71. Lung Neoplasms 11%
72. Prostate 11%
73. Primary Myelofibrosis 11%
74. Colonic Neoplasms 10%
75. B-Cell Lymphoma 10%
76. In Vitro Techniques 10%
77. Estrogen Receptors 10%
78. Lymph Nodes 10%
79. Amyloid 10%
80. Hepatocellular Carcinoma 10%
81. Plasma Cells 10%
82. Glomerulonephritis 10%
83. Adenoma 10%
84. Alzheimer Disease 10%
85. Germ-Line Mutation 10%
86. Exons 10%
87. Paraffin 10%
88. Non-Hodgkin's Lymphoma 9%
89. Progression-Free Survival 9%
90. Brain 9%
91. Neoplasm Genes 9%
92. Allografts 9%
93. Histology 9%
94. Neuromyelitis Optica 9%
95. Leukemia 9%
96. Autopsy 9%
97. Chromosome Aberrations 9%
98. Inflammation 9%